Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Recurrence × zanubrutinib × Clear all

Status

Recruiting 4 Completed 4 Unknown 2 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Recurrence 1

Interventions

zanubrutinib 1 sugemalimab 1 revumenib 1 loncastuximab tesirine 1 fludarabine phosphate 1 denileukin diftitox 1 Whole-Body Irradiation 1 Tacrolimus 1 Panobinostat 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04052854 2024-10-23

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

BeiGene

No longer available

Waldenstrom Macroglobulinemia, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡